SAN FRANCISCO, Jan. 31, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on February 11, 2014 to discuss the Company's financial results for the third quarter of fiscal 2014 and to provide an update about the business in the current fiscal year.
The dial-in number for the live audio call beginning on Tuesday, February 11, 2014, at 5 p.m. EST (2 p.m. PST) is (877) 369-6591 in the U.S. and (253) 237-1176 for international participants. The conference identification number is 55844679. A live webcast of the conference call will also be available at: http://www.media-server.com/m/p/ufv9tb4k
A webcast replay of the call will be available for one year and may be accessed at the same link: http://www.media-server.com/m/p/ufv9tb4k
CollabRx, Inc. (Nasdaq:CLRX) is a data analytics company and a leader in cloud-based expert systems to inform health care decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care. More information may be obtained at http://www.collabrx.com.
CONTACT: CollabRx Contacts: Thomas R. Mika, Chairman and CEO CollabRx, Inc. 415-248-5350 James Carbonara, Regional Vice President Hayden IR 646-755-7412 James@haydenir.com